Heather Sandness-Nelson, MD
Obstetrics & Gynecology · Bismarck, NDNPI 1265872212
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 92.7% of the total across 83 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 18 manufacturers reported payments, led by Astellas Pharma US Inc at 31.8% of the total. Reporting peaked in 2021 at $514 and has fallen 95.9% since, to $21 in 2024.
Across 83 payments — averaging $20.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Astellas Pharma US Inc$540
- AbbVie$481
- Coopersurgical, Inc.$155
- Baxter Healthcare$85
- Coloplast$72
- Daiichi Sankyo Inc.$68
- plus $299 from 12 others
What the payments were for
- Food & beverage$1,57593%
- Education$1247%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Astellas Pharma US Inc | 33 | $540 |
| AbbVie(2 entities) | 19 | $481 |
| Coopersurgical, Inc. | 4 | $155 |
| Baxter Healthcare | 1 | $85 |
| Coloplast | 4 | $72 |
| Daiichi Sankyo Inc. | 4 | $68 |
| Pfizer | 1 | $52 |
| Myovant Sciences Inc. | 3 | $49 |
| Boston Scientific | 2 | $36 |
| Merck | 2 | $25 |
| Radius Health, Inc. | 1 | $21 |
| Organon | 3 | $21 |
| Exeltis, USA Inc. | 1 | $20 |
| Roche Diagnostics Corporation | 1 | $18 |
| Dermira, Inc. | 1 | $16 |
| Smith+Nephew | 1 | $15 |
| GSK | 1 | $13 |
| Hologic Sales And Service, LLC | 1 | $13 |
How this compares
$1,699 in reported general payments places this provider in the 80th percentile of 86 obstetrics & gynecology providers in North Dakota.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 48 | $4,198 |
| Paroxetine Hcl | 11 | $201 |
| Alendronate Sodium | 11 | $119 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Bismarck
- Thomas HutchensBismarck$53K
- Jerry ObritschBismarck$23K
- Shannon BradleyBismarck$7K
- Joshua SaylerBismarck$6K
- Sarah ClausenBismarck$5K
- Marissa WisdomBismarck$4K
- Kathleen PerkerewiczBismarck$3K
- Cassondra KambeitzBismarck$2K
- Kristin GrayBismarck$2K
- Jill SteinleBismarck$936
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.